Breaking News Instant updates and real-time market news.

DIS

Disney

$110.57

2.96 (2.75%)

, FOX

21st Century Fox

$34.22

1.88 (5.81%)

18:31
12/14/17
12/14
18:31
12/14/17
18:31

Experts: Disney-Fox deal may raise antitrust worries, Reuters reports

Competition experts say that Disney's (DIS) deal to acquire a number of 21st Century Fox (FOX) assets could draw the attention of U.S. antitrust regulators, Reuters reports. "Any combination of sports programming is going to trigger significant scrutiny. They'll look at the competition between ESPN and the regional sports networks," Caroline Holland, a veteran of the U.S. Justice Department's Antitrust Division, told Reuters. Holland added that antitrust regulators would be interested to know if a more powerful Disney sports franchise would give it the clout to increase prices for cable operators and internet TV providers, the report notes. Five antitrust experts said this week that the agreement would likely be approved by the U.S. Justice Department, although the agency may require asset sales or conditions, the report says. Reference Link

DIS

Disney

$110.57

2.96 (2.75%)

FOX

21st Century Fox

$34.22

1.88 (5.81%)

FOXA

21st Century Fox

$34.88

2.13 (6.50%)

  • 14

    Dec

  • 14

    Dec

  • 14

    Dec

  • 15

    Dec

DIS Disney
$110.57

2.96 (2.75%)

12/14/17
HDLY
12/14/17
NO CHANGE
HDLY
Hilliard Lyons Top Ideas for Year-End 2017
Hilliard Lyons Research named its Top Ideas for Year-End 2017. They are: Pinnacle Financial (PNFP), Disney (DIS), J.M. Smucker (SJM), NextEra Energy (NEE), Zoetis (ZTS), Leggett & Platt (LEG), South Jersey Industries (SJI), Tanger Factory (SKT), Physicians Realty Trust (DOC), VMware (VMW), AT&T (T), and American Water (AWK).
12/14/17
PIPR
12/14/17
NO CHANGE
Target $120
PIPR
Overweight
Fox deal brings 'significant' opportunities for Disney, says Piper Jaffray
Piper Jaffray analyst Stan Meyers believes the acquisition of 21st Century Fox (FOXA) assets creates "significant" growth opportunities for Disney (DIS). For Disney, the deal unlocks a "vast wealth" of intellectual property, integrates "vast" distribution capabilities, launches and expands direct-to-consumer offerings, and extracts improved economics via scale from its counterparties, Meyers investors in a research note. The analyst keeps an Overweight rating on the shares with a $120 price target.
12/14/17
RBCM
12/14/17
NO CHANGE
RBCM
RBC Capital sees Disney, 21st Century Fox transaction as 'deal of the decade'
Calling it the "deal of the decade," RBC Capital analyst Steven Cahall notes that Disney (DIS) and 21st Century Fox (FOXA) announced their much anticipated deal at terms generally in-line with prior media reports. The analyst believes it to be an accretive deal for Disney, seeing further upside to the company longer term coming from the efficacy of the strategy. Regarding 21st Century Fox, Cahall does not think investors have much to worry about.
12/14/17
RSBL
12/14/17
NO CHANGE
RSBL
21st Century Fox should trade at a minimum of $37, says Rosenblatt
Rosenblatt said 21st Century Fox (FOXA) should be trading at a minimum of $37 per share today assuming Disney's (DIS) current price of $110, a conservative value for the tax shield and a 15% arbitrage discount. The firm believes the deal will pass regulatory scrutiny with the possible exception of the Regional Sports Network, for which Disney should be able to find willing buyers.
FOX 21st Century Fox
$34.22

1.88 (5.81%)

11/10/17
BERN
11/10/17
NO CHANGE
Target $101
BERN
Market Perform
Disney deal for Fox wouldn't solve underlying problems, says Bernstein
Bernstein analyst Todd Juenger noted that Disney (DIS) has gone from a situation where reported EPS was going up but its stock price was going down to one where EPS is going down but the stock has been going up a bit driven by M&A speculation. However, he contends that the current round of renewed M&A speculation is happening because underlying fundamentals are "so bad" and even if a deal for Disney to buy Fox (FOXA) assets happens it wouldn't solve the underlying problems. He also thinks the chances of a Disney-Fox deal as currently described are "very low." Juenger maintains a Market Perform rating and $101 price target on Disney shares.
12/11/17
BTIG
12/11/17
NO CHANGE
BTIG
BTIG says Comcast could pay 'significantly' more for Fox assets than Disney
BTIG analyst Richard Greenfield said earlier in a note to investors that he believes Comcast (CMCSA) could pay "significantly more" for the assets that Fox (FOXA) is reportedly looking to sell than could Disney (DIS). He also believes Comcast could have a better chance of securing regulatory approval for a deal if they are willing to spin off all of the regional sports networks that a combined entity would own.
12/13/17
FBNS
12/13/17
NO CHANGE
FBNS
FBN says Fox could be worth over $42 per share with Disney deal
With multiple media report indicating that Disney (DIS) is close to finalizing a deal to buy most of 21st Century Fox's (FOX) assets and operations, FBN Securities analyst Robert Routh is estimating that Fox shares could have a "real value" of $42.46 based on what has been reported on the likely deal. This estimate is before considering taxes and taking into account that Disney shares will likely rise after a deal is confirmed, said Routh, who does not officially cover either Disney or Fox.
12/13/17
BTIG
12/13/17
NO CHANGE
BTIG
Disney, Fox deal may be a near-term positive for Netflix, BTIG says
Commenting on Disney's (DIS) deal with Fox (FOX; FOXA) and its potential implications, BTIG's Richard Greenfield notes that the knee jerk reaction he hears across the investment world is the former is buying the later to build their "Netflix killer." Greenfield "strongly disagrees" with this viewpoint, saying that if Disney wanted to build a Netflix competitor it should be eliminating its stock buyback and aggressively investing in content that has no legacy media strings attached. Further, the Disney/Fox transaction is likely a near-to-intermediate term positive for Netflix, he argues, adding that both companies will be tied up in a 12 month or more regulatory review process with thousands of executives in limbo pending the closing of the transaction.
FOXA 21st Century Fox
$34.88

2.13 (6.50%)

TODAY'S FREE FLY STORIES

10:40
10/16/18
10/16
10:40
10/16/18
10:40
General news
Treasury Option Action: put positioning has resumed »

Treasury Option Action:…

FXI

iShares China Large-Cap ETF

$39.90

0.41 (1.04%)

10:40
10/16/18
10/16
10:40
10/16/18
10:40
Options
Size call spread bought in China ETF appears opening »

Size call spread bought…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:40
10/16/18
10/16
10:40
10/16/18
10:40
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

MS

Morgan Stanley

$45.22

1.77 (4.07%)

10:39
10/16/18
10/16
10:39
10/16/18
10:39
Upgrade
Morgan Stanley rating change  »

Oppenheimer upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

BBT

BB&T

$46.52

-0.26 (-0.56%)

10:31
10/16/18
10/16
10:31
10/16/18
10:31
Hot Stocks
BB&T to build approx. 100,000 square foot facility in Whiteville »

BB&T Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

MOMO

Momo

$37.24

-0.82 (-2.15%)

10:30
10/16/18
10/16
10:30
10/16/18
10:30
Options
Momo puts active as shares see relative weakness »

Momo puts active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$337.99

4.88 (1.47%)

10:29
10/16/18
10/16
10:29
10/16/18
10:29
Earnings
Fly Intel: What to watch in Netflix earnings report »

Netflix (NFLX) is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 13

    Nov

IRBT

iRobot

$93.11

2.25 (2.48%)

10:25
10/16/18
10/16
10:25
10/16/18
10:25
Upgrade
iRobot rating change  »

iRobot upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:25
10/16/18
10/16
10:25
10/16/18
10:25
Conference/Events
UBS technology analyst to hold an analyst/industry conference call »

Technology Analyst…

10:25
10/16/18
10/16
10:25
10/16/18
10:25
Conference/Events
Morgan Stanley to hold an analyst/industry conference call »

Vice President Kaufman…

ABT

Abbott

$69.86

1.14 (1.66%)

, BSX

Boston Scientific

$37.64

1.21 (3.32%)

10:23
10/16/18
10/16
10:23
10/16/18
10:23
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

ABT

Abbott

$69.86

1.14 (1.66%)

BSX

Boston Scientific

$37.64

1.21 (3.32%)

SYK

Stryker

$172.45

3.03 (1.79%)

MDT

Medtronic

$95.39

1.58 (1.68%)

BAX

Baxter

$71.00

0.12 (0.17%)

EW

Edwards Lifesciences

$144.31

2.36 (1.66%)

ZBH

Zimmer Biomet

$124.31

0.72 (0.58%)

EXPE

Expedia

$120.28

1.73 (1.46%)

TRIP

TripAdvisor

$46.17

1.17 (2.60%)

BKNG

Booking Holdings

$1,824.49

12.59 (0.69%)

FB

Facebook

$156.16

2.6 (1.69%)

SNAP

Snap

$7.23

-0.18 (-2.43%)

VFC

VF Corp.

$88.01

0.36 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 28

    Oct

  • 30

    Oct

  • 31

    Oct

  • 05

    Nov

  • 07

    Nov

  • 08

    Nov

  • 13

    Nov

  • 15

    Nov

PF

Pinnacle Foods

$66.43

0.2 (0.30%)

, AMRX

Amneal Pharmaceuticals

$18.05

-0.68 (-3.63%)

10:23
10/16/18
10/16
10:23
10/16/18
10:23
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…

PF

Pinnacle Foods

$66.43

0.2 (0.30%)

AMRX

Amneal Pharmaceuticals

$18.05

-0.68 (-3.63%)

SCCO

Southern Copper

$41.72

-0.42 (-1.00%)

SNN

Smith & Nephew

$34.42

0.28 (0.82%)

SPRO

Spero Therapeutics

$8.19

-1.64 (-16.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 07

    Nov

  • 28

    Feb

SYMC

Symantec

$19.92

0.14 (0.71%)

, LVS

Las Vegas Sands

$56.55

0.71 (1.27%)

10:23
10/16/18
10/16
10:23
10/16/18
10:23
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…

SYMC

Symantec

$19.92

0.14 (0.71%)

LVS

Las Vegas Sands

$56.55

0.71 (1.27%)

CGNX

Cognex

$46.21

2.11 (4.78%)

TPR

Tapestry

$43.55

0.46 (1.07%)

CBRL

Cracker Barrel

$156.00

2.86 (1.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

  • 19

    Nov

  • 06

    Dec

JNJ

Johnson & Johnson

$137.42

3.67 (2.74%)

, SYK

Stryker

$172.58

3.16 (1.87%)

10:22
10/16/18
10/16
10:22
10/16/18
10:22
Recommendations
Johnson & Johnson, Stryker, Zimmer Biomet, Globus Medical, NuVasive, SeaSpine, Cooper Companies, Insulet, TNDM analyst commentary  »

Piper Jaffray discusses…

JNJ

Johnson & Johnson

$137.42

3.67 (2.74%)

SYK

Stryker

$172.58

3.16 (1.87%)

ZBH

Zimmer Biomet

$124.31

0.72 (0.58%)

GMED

Globus Medical

$52.54

0.57 (1.10%)

NUVA

NuVasive

$66.97

1.36 (2.07%)

SPNE

SeaSpine

$15.96

-0.03 (-0.19%)

COO

Cooper Companies

$254.67

1.63 (0.64%)

PODD

Insulet

$90.55

1.64 (1.84%)

TNDM

TNDM

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

  • 19

    Oct

  • 25

    Oct

  • 26

    Oct

  • 28

    Oct

  • 30

    Oct

  • 01

    Nov

  • 27

    Nov

TVTY

Tivity Health

$32.62

0.39 (1.21%)

10:22
10/16/18
10/16
10:22
10/16/18
10:22
Hot Stocks
Tivity says SilverSneakers coming to North Carolina, California MA members »

Tivity Health announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 27

    Nov

QCOM

Qualcomm

$65.29

1.11 (1.73%)

10:20
10/16/18
10/16
10:20
10/16/18
10:20
Options
Aggressive call buying in Qualcomm »

Aggressive call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

10:20
10/16/18
10/16
10:20
10/16/18
10:20
General news
U.S. JOLTS report showed job openings rose 59k to 7,136k in August »

U.S. JOLTS report showed…

10:20
10/16/18
10/16
10:20
10/16/18
10:20
General news
Treasury Action: yields rebounded from lows »

Treasury Action: yields…

TROX

Tronox

$11.91

0.05 (0.42%)

10:20
10/16/18
10/16
10:20
10/16/18
10:20
Conference/Events
UBS basic materials analyst to hold an analyst/industry conference call »

Analyst Roberts discuss…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 06

    Nov

GS

Goldman Sachs

$218.11

2.83 (1.31%)

10:19
10/16/18
10/16
10:19
10/16/18
10:19
Hot Stocks
Breaking Hot Stocks news story on Goldman Sachs »

Goldman expects to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

TVTY

Tivity Health

$32.62

0.39 (1.21%)

10:19
10/16/18
10/16
10:19
10/16/18
10:19
Hot Stocks
Tivity says SilverSneakers available to Ohio MA members in 2019 »

Tivity Health announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 27

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
10/16/18
10/16
10:17
10/16/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
10/16/18
10/16
10:16
10/16/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$276.93

2.31 (0.84%)

, SPX

S&P 500

$0.00

(0.00%)

10:14
10/16/18
10/16
10:14
10/16/18
10:14
General news
Trump says 'it's all working,' citing 'incredible' job openings data »

President Donald Trump…

SPY

SPDR S&P 500 ETF Trust

$276.93

2.31 (0.84%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TVTY

Tivity Health

$32.62

0.39 (1.21%)

10:13
10/16/18
10/16
10:13
10/16/18
10:13
Hot Stocks
Tivity says SilverSneakers available to Wisconsin MA members in 2019 »

Tivity Health announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 27

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.